Fadi Haddad

This discussion features Dr. Fadi Haddad, a hematologist-oncologist specializing in chronic myeloid leukemia (CML) and TKI management, alongside Dr. Onyee Chan, an expert in CML toxicities and patient counseling. They explore the various generations of tyrosine kinase inhibitors and their class-wide toxicities. Key topics include unique side effects of each TKI, strategies for dose optimization, and the critical role of patient education in managing complications effectively. They also delve into specific drug issues, including dasatinib monitoring and bosutinib's GI side effects.